Infant RSV mRNA Injection Trials Paused Due to Safety Concerns
by Nicolas Hulscher, MPH The FDA has just released a briefing document for the December 12, 2024, Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting titled, Considerations for Respiratory Syncytial Virus (RSV) Vaccine Safety in Pediatric Populations. The document revealed that, in July 2024, a Phase 1 trial assessing the safety, tolerability, and immunogenicity […]
Discuss on Nostr!
Nostr Note ID note1auv8pnggr5ks6xt8py54sk933qre5nrymgjhhhk0m9lt3x0fne3s6gq5c8 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.